Here are relevant reports on : vector-network-analyzer-market
-
Vector Database Market By Vector Database Solution (Vector Generation & Indexing, Vector Search & Query Processing, Vector Storage & Retrieval), AI Language Processing, Computer Vision, Recommendation Systems - Global Forecast to 2030
The vector database market is expected to grow from USD 2,652.1 million in 2025 to USD 8,945.7 million by 2030, at a compound annual growth rate (CAGR) of 27.5% during the forecast period. The Key Players Microsoft (US), Elastic (US), MongoDB (US), Google (US), AWS (US), Redis (US), Alibaba Cloud(US), DataStax (US), SingleStore (US), Pinecone (US), Zilliz (US), KX (US), Marqo.ai (US), ActiveLoop (US), Supabase (US), Jina AI (Germany), Typesense (US), Weaviate (Netherlands), GSI Technology (US), Kinetica (US), Qdrant (Germany), ClickHouse (US), OpenSearch (US), Vespa.ai (Norway), and LanceDB (US).
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
Vector Control Market by Technology (Chemical, Physical & Mechanical, Biological), Control Method (Comprehensive, Integrated Vector Management, Targeted), Vector Type, End-Use Sector, Mode of Application and Region - Global Forecast to 2029
The market for vector control is projected to reach USD 29.80 billion by 2029, at a CAGR of 6.5% during the forecast period. The report profiles key players such as BASF SE (Germany), Rentokil Initial Plc (UK), Sumitomo Chemical Co., Ltd. (Japan), Syngenta Group (Switzerland), FMC Corporation (US), Ecolab (US), Rollins Inc. (US), Anticimex (Sweden), UPL (India), Neogen Corporation (US), Senestech, Inc. (US), Environmental Science U.S. Inc. (US), Bell Laboratories Inc. (US), Pelgar International (UK), S. C. Johnson & Son, Inc. (US).
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Viral Vector & Plasmid DNA Manufacturing Market by Type (Viral Vector (Retroviruses, Adenoviruses, AAV, Lentiviruses), Plasmid DNA), Workflow (Upstream, Downstream), Application (Cell & Gene Therapy), Diseases (Cancer), End User - Global Forecast to 2028
The global viral vector manufacturing market, valued at US$4.8 billion in 2022, stood at US$5.5 billion in 2023 and is projected to advance at a resilient CAGR of 18.2% from 2023 to 2028, culminating in a forecasted valuation of US$12.8 billion by the end of the period. The growth of this market is majorly driven by g rising prevalence of target diseases and disorders, the availability of funding for gene therapy development, and effectiveness of viral vectors in gene therapy delivery.
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
Network Traffic Analyzer Market by Component (Solutions and Professional Services), Deployment Mode (Physical, Virtual, and Cloud), End users (Service Providers and Enterprises), Enterprise Size, and Region - Global Forecast to 2024
The global network traffic analyzer market size is expected to grow from USD 1.9 billion in 2019 to USD 3.2 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 10.6% during the forecast period. Major network traffic analyzer vendors providing a host of solutions and services include SolarWinds (US), Netscout (US), Broadcom (US), Nokia (Finland), Opmantek (US), Progress (US), Kentik (US), Colasoft (China), ManageEngine (US), NEC (Japan), NetVizura (Serbia), Plixer (US), MixMode (US), Opsview (UK), Inmon (US), Nagios (US), Corelight (US), Awake (US), IdeaData (Australia), Qosmos (France), Dynatrace (US), Sandvine (Canada), Extrahop (US), LiveAction (US) and LogRhythm (US). The study includes an in-depth competitive analysis of these key players, along with their company profiles, recent developments, and key growth strategies.
- Published: February 2020
- Price: $ 4950
- TOC Available:
-
Tunable Diode Laser Analyzer (TDLA) Market by Gas Analyzer (Oxygen, Ammonia, COx, Hx, Moisture, CxHx, NxOx), Device (Portable, Fixed), Methodology (In Situ, Extractive), Technology (Absorption, Emission), Operation, Component - Global Forecast to 2031
The global tunable diode laser analyzer (TDLA) market is expected to grow from USD 546.2 million in 2024 to USD 884.4 million by 2031, at a compound annual growth rate (CAGR) of 7.1% during the forecast period.The key players Yokogawa Electric Corporation (Japan), Emerson Electric Co. (US), Spectris (UK), AMETEK.Inc. (US), METTLER TOLEDO (US), Endress+Hauser Group Services AG (Switzerland), ABB (Switzerland), SICK AG (Germany), Siemens (Germany), SENSIT Technologies (US), Pergam-Suisse AG (Switzerland), Tokyo Gas Engineering Solutions Corporation (Japan), Heath Consultants Incorporated (US), Hanwei Electronics Group Corporation (China), and Baker Hughes Company (US).
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Network Automation Market by Network Automation Type (Orchestration Automation, Provisioning Automation, Script-driven Network Automation, Intelligent Network Automation, IBN Automation, Network Security Automation) - Global Forecast to 2030
The global network automation market is projected to grow from USD 7.88 billion in 2025 to USD 12.38 billion by 2030, at a compound annual growth rate (CAGR) of 9.4% during the forecast period. The major vendors in the network automation market are Cisco (US), IBM (US), HPE (US), Huawei (China), VMware (US), Arista Networks (US), Nokia (Finland), Ericsson (Sweden), Extreme Networks (US), and Fujitsu (Japan).
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Network Transformation Market by Solution (SDN and NFV, C-RAN, Network Automation and 5G Networks), Professional Service, Managed Services (Network Monetization, Network Management, Network Testing),Vertical, and Region - Global Forecast to 2022
The network transformation market size is expected to grow from USD 4.28 Billion in 2016 to USD 66.86 Billion by 2022, at a Compound Annual Growth Rate (CAGR) of 61.9% during 2017–2022. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022. The major vendors in the network security firewall market include Cisco, Juniper Networks, HPE, Huawei, IBM, NEC, Intel, Nokia Networks, Ericsson, FUJITSU, Accenture, and Mavenir.
- Published: September 2017
- Price: $ 4950
- TOC Available:
-
Europe Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR, RSV), Route of Administration (IM, SC, Oral) - Forecast to 2030
The Europe vaccines market, valued at US$10.53 billion in 2024, stood at US$9.97 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2025 to 2030, culminating in a forecasted valuation of US$13.74 billion by the end of the period. The vaccines market is growing due to fast global developments and the commercialization of vaccines, rising rates of infectious diseases, which require preventive measures, and government initiatives to encourage vaccinations, immunization programs, advancements, and investments in new vaccines against various diseases.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Gene Editing Market by Product (Kits, Reagents, Libraries, Software), Services (gRNA Synthesis & Vector Construction), Technique (Knock-Out, Knock-In), Technology (CRISPR, ZFN, TALEN), Application (Genome Editing, Drug Discovery) - Global Forecast to 2029
The global gene editing market, valued at US$4.44 billion in 2023, stood at US$4.66 billion in 2024 and is projected to advance at a resilient CAGR of 10.2% from 2024 to 2029, culminating in a forecasted valuation of US$7.59 billion by the end of the period. The main factors driving the expansion of this market are the demand for personalized medicine and favorable government funding for gene editing projects.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Asia Pacific Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR), Route of Administration (IM, SC, Oral) - Forecast to 2030
The global Asia Pacific Vaccines market, valued at US$9.89 billion in 2024, stood at US$9.46 billion in 2025 and is projected to advance at a resilient CAGR of 9.0% from 2025 to 2030, culminating in a forecasted valuation of US$14.57 billion by the end of the period. The market is expanding quickly, driven by a rise in vaccine development and commercialization, heightened infectious disease rates, and the extensive use of preventive vaccines.
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
